Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certification & Accreditation
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Systemic ketoconazole continues to be prescribed despite an FDA warning
By
- AMS
posted
Oct 20, 2020 08:45 AM
0
Recommend
.
0 comments
0 views
Related Content
FDA Strengthens Safety Requirements and Updates Study Results for Breast Implants
- AMS
Added Nov 10, 2021
Blog Entry
Aesthetic Medicine in 2023: Review of What's Here and What's Yet to Be
The Aesthetic GUIDE
Added 18 days ago
Blog Entry
U.S. FDA Approves New MENTOR MemoryGel BOOST Breast Implant
- AMS
Added Jan 21, 2022
Blog Entry
Thread Lifting in 2022: The Evolution Continues
Informa Admin
Added Nov 30, 2022
Blog Entry
Minimally Invasive Advances Continue to Shape the Future of Aesthetics
The Aesthetic GUIDE
Added 8 hours ago
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic